Open access peer-reviewed chapter

Multiple Functions and Disordered Nature of Nucleocapsid Proteins of Retroviruses and Hepadnaviruses

Written By

Jean Luc Darlix and Hugues de Rocquigny

Submitted: May 27th, 2019 Reviewed: December 2nd, 2019 Published: June 17th, 2020

DOI: 10.5772/intechopen.90724

From the Edited Volume

Viruses and Viral Infections in Developing Countries

Edited by Snežana Jovanović-Ćupić, Muhammad Abubakar, Ayşe Emel Önal, Muhammad Kashif Saleemi, Ana Božović and Milena Krajnovic

Chapter metrics overview

648 Chapter Downloads

View Full Metrics


This chapter aims at presenting small viral proteins that orchestrate replication of the human immunodeficiency virus type-1 (HIV-1) and the human hepatitis virus (HBV), two canonical examples of small human pathogens. HIV-1 nucleocapsid protein (NC) and the C-terminal domain (CTD) of the HBV core protein (HBc) are essential structural components of the virus capsid ensuring protection of the viral genome; they also chaperone replication of the HIV-1 genomic RNA and the HBV DNA by a reverse-transcription mode, and later, these proteins kick-start virus morphogenesis. HIV-1 NC and HBV CTD belong to the family of intrinsically disordered proteins (IDP), a characteristic rendering possible a large number of molecular interactions. Although these viral proteins share little sequence homologies, they have in common to be rich in basic amino acids and endowed with RNA-binding and chaperoning activities. Similar viral RNA-binding proteins (vRBP) are also encoded for by other virus families, notably flaviviruses, hantaviruses, and coronaviruses. We discuss how these vRBPs function based on the abundant RBP family that plays key physiological roles via multiple interactions with non-coding RNA regulating immune defenses and cell stress. Moreover, these RBPs are flexible molecules allowing dynamic interactions with many RNA and protein partners in a semi-solid milieu favoring biochemical reactions.


  • RBP
  • HIV
  • HBV
  • IDP
  • RNA chaperoning
  • molecular crowding

1. Forewords on viruses and RNA chaperones

Viruses that replicate their genome by the process of reverse transcription (RTion) are common in animals, plants, algae, and fungi [1]. These so-called reverse-transcribing viruses have been classified into five different families, namely, Caulimoviridae, Hepadnaviridae, Metaviridae, Pseudoviridae, and Retroviridaeto which was the recently added Belpaoviridae[2]. Among these widespread viruses, two are major human pathogens, the human immunodeficiency virus type 1 (HIV-1) and the human hepatitis B virus (HBV).

Retroviruses exist as infectious exogenous RNA viruses as well as endogenous retroelements (ERV) present at high copy numbers in the genome of vertebrates. Hepadnaviruses can also integrate their genome in the host genome but at a much lower rate [3].

Replication of the genome of these two classes of virus necessitates a reverse transcription step. For HIV-1 the genomic RNA of 9600 nt in length has a structure similar to cellular mRNAs with a 5′ cap and 3′ poly A and contains 9 genes leading to the expression of 15 proteins. Retroviruses replicate their genome by a copy and paste mechanism, whereby the single-stranded positive-sense retroviral genomic RNA is converted into a double-stranded DNA by the virion reverse transcriptase (RT enzyme) [4], subsequently integrated into the host genome [5]. The integrated viral DNA called provirus is expressed by the host transcription machinery to synthesize the full-length viral RNA (FL RNA), which after nuclear export in the cell cytoplasm is translated by the ribosomes to synthesize the major structural proteins and enzymes, the Gag and Gag-Pol precursors. Specific interactions of the genomic RNA with the Gag polyprotein precursor drive Gag polymerization and viral core assembly at the plasma membrane (PM) [6].

For hepadnaviruses the small double-stranded DNA genome in a relaxed circular form (rcDNA) is targeted to the nucleus after virus infection where it is converted into a covalently closed circular form (cccDNA) and expressed by the transcription machinery of the infected cell to synthesize the full-length RNA called pre-genomic RNA (pgRNA) [7]. Upon translation of the pgRNA, the newly made core protein and RT enzyme interact with the pgRNA to synthesize the ds DNA genome. The genome of this virus has unique features such as an extensive overlapping of the genes, namely, 3200 nt with four coding sequences leading to the expression of seven proteins for HBV, and a pseudo-circular structure [8]. In addition several of the HIV and HBV proteins were found to be multifunctional, notably NC, TAT, and VIF protein for HIV and the HBV core protein (HBc) [9, 10].

These two classes of viruses probably emerged during the early Paleozoic Era, some 450–520 million years ago, with a marine origin [11]. The HBVs seem to originate from non-enveloped progenitors called nackednaviruses present in fishes, some 400 million years ago [12].

In addition to an RNA/DNA-dependent DNA polymerase called reverse transcriptase with an associated RNase H activity, these two classes of small viruses encode for a core protein endowed with RNA-binding, unwinding, annealing, and matchmaker activities and the ability to cause the formation of nucleoprotein complexes with a gel-like milieu favoring molecular crowding and biochemical reactions such as reverse transcription.

This chapter will briefly review the multiple roles of the core proteins drawing a parallel between the HIV-1 Gag and the HBV core. In fact these viral core proteins turn out to be much more than a structural component forming a cage enveloping the genome since they provide assistance to the RT-RNase H enzyme at all steps of viral DNA synthesis and then ensure stability of the newly made viral DNA.

Despite common functions in HIV and HBV morphogenesis and replication, the core protein appears much different from Gag on an amino acid sequence basis, but taking a closer look at their activities and functions reveals that these viral proteins are similar.


2. The RNA folding problem and RNA chaperones

The need for RNA chaperones comes from the RNA folding problem whereby RNA molecules have to find their native functional structure in an extremely wide landscape of structures [13]. In fact, RNA chaperones are as diverse and abundant as RNA molecules, coding and noncoding from prokaryotes to eukaryotes [14]. Recent findings highlight the fact that RNA chaperones are disordered in nature and function in a disordered state and do not require ATP as a source of energy to direct RNA folding [13]. Instead RNA chaperones seem to exploit a mechanism of an energy transfer during a rapid on-off RNA-binding kinetics. A number of standard assays are used to monitor RNA chaperoning activity; notably binding, fraying, and annealing of complementary sequences; activation of hammerhead ribozyme-directed cleavage of an RNA substrate; and formation of a dense nucleoprotein complexes. Figure 1 illustrates assays aimed at describing the influence of NC on DNA strand transfers that occur during the process of reverse transcription resulting in the synthesis of cDNA.

Figure 1.

Standard assays for monitoring the nucleic acid chaperone activity. These in vitro chaperoning assays summarize several properties of nucleic acid chaperone proteins, notably their ability to rapidly anneal complementary nucleic acid sequences (top panel) and favor formation of the most stable duplex, in physiological-like conditions. Bottom panel: R+ and R− sequences represent the 5′ end repeats of the HIV-1 genome of 96 nt in length. R− (mut) contains three mutated residues at its 3′ end in order to generate 3 nt mismatch upon annealing to R+; this was achieved by incubating R+ and R− mut at 66°C for 1 h. Next R− WT is added together with NC protein for 5 min at 30°C. The duplex and ss R− mut were resolved by native gel electrophoresis. Adapted from Darlix et al. [15].


3. The retroviral GAG polyprotein and its multiple roles

The major structural proteins of retroviruses are encoded for by Gag that is formed of several modular domains, namely, Map17, Cap24, NCp7, and p6; in addition there are two small peptides p1 and p2 flanking NC in the Pr55 gag (Figure 2) [16]. The N-terminus is myristoylated, which, together with a row of basic residues within MA, targets Gag to the plasma membrane where assembly takes place [17].

In infected cells the full-length viral RNA is translated by the ribosome machinery to produce the Gag and Gag-Pol polyprotein precursors. The present model of assembly stipulates that newly made Gag molecules accumulate in the cytoplasm, probably in the vicinity of the translating polysomes [18] where they kick-start virus assembly (Figure 3); this is achieved through two types of interactions (i) Gag-NC with the 5′ untranslated region (5′ UTR) of FL RNA [19] and (ii) the myristoylated matrix domain with phospholipids of the T-cell membrane [20]. These interactions target the Gag-RNA nucleoprotein complexes to the plasma membrane, causing Gag-oligomer formation; the nucleocapsid domain binds and selects the genomic RNA causing its dimerization and at the same time, together with the capsid domain, boosts Gag multimerization (Figure 3). These interactions between Gag and phospholipids as well as RNA lead to virus assembly that takes place at the plasma membrane. Subsequently, virus maturation occurs during the budding process, together with the recruitment of the envelope glycoproteins by the matrix domain [21] (Figure 3).

Figure 2.

Structural model of the HIV-1 Gag polyprotein precursor. Left, the different domains of HIV-1 Gag, matrix (Map17), capsid (Cap24), nucleocapsid (NCp7), and p6; two small peptides flanking the NC domain, P2/SP1 and P1/SP2. Right: 2D presentation of the complete Gag Pr55. Adapted from Sundquist and Krausslich [16].

Figure 3.

Schematic representation of virus morphogenesis and the roles of Gag-NC. The genomic RNA is exported from the nucleus and translated by the cell ribosome machinery giving rise to the production of the Gag and Gag-Pol precursors. Gag-NC binds the packaging signal at the 5′ end of the genomic RNA causing the formation of the viral nucleoprotein complex (vRNP) and dimerization of the genomic RNA. Such vRNP are targeted to the plasma membrane where they accumulate to form immature viral particles. Next, the Gag molecules are processed by the viral protease causing core condensation. Adapted from Muriaux and Darlix [22].

Maturation is a complex process whereby the core of HIV-1 becomes conical and at the same time the genomic RNA dimer is condensed, thus leading to the formation of infectious particles [23]. However most HIV-1 virions and more generally retroviral particles are noninfectious. As a matter of fact, the ratio of infectious virus to noninfectious particles is from 1:10 to 1:104 [24, 25]. Thus a majority of particles are noninfectious most probably caused by the loss of envelope proteins, degradation of the genomic RNA, or else correspond to defective-interfering particles (DIP) that can lead to an underestimation of virus infectivity [26].


4. Characteristics of retroviral nucleocapsid proteins

Retroviral nucleocapsid proteins are small basic proteins with either one (MuLV, gammaretrovirus) or two CCHC zinc fingers (HIV and FIV, lentiviruses; RSV an Alpharetrovirus) (Table 1). The zinc fingers are structured upon Zn2+ binding (in red), while the flanking domains are disordered and basic. Therefore, these viral proteins are members of the large family of intrinsically disordered proteins/intrinsically disordered protein domains (IDPDs) [27, 28, 29]. Of note all these NC proteins are endowed with RNA-binding and chaperoning activities as shown using in vitro reconstituted systems [15, 30, 31, 32]. Other important characteristics are the ability of these NC proteins to cause the formation of nucleoprotein complexes capable of recruiting enzymes such as reverse transcriptase and integrase (IN) [33]. In this gel-like milieu, molecular crowding can take place, thus facilitating enzymatic reactions, such as cDNA synthesis by RT and integration by IN. Along this line, NC protein interacts with RT improving the fidelity of cDNA synthesis by several different ways: (i) inhibition of self-primed initiation of cDNA synthesis, (ii) chaperoning the obligatory minus- and plus-stranded transfers for the synthesis of the LTR flanking the viral DNA (Figure 1), and (iii) improving the processivity of RT as well as its excision repair activity resulting in a much higher fidelity of viral DNA synthesis (Figure 1 on chaperoning assays).

Table 1.

Sequences of retroviral nucleocapsid proteins and the C-terminus of HBV core protein. The one-letter code has been used, and the basic domains are in black, while the CX2CX4HX2C zinc fingers are in red. Note the low complexity basic domains flanking the NC zinc fingers. For the yeast retrotransposon Ty3, note the zinc finger essential for TY3 retrotransposition and the low complexity flanking sequences. The C-terminal domain of the HBV core protein has four R-rich sequences and is of low complexity.

How is this achieved? According to Uversky, protein-RNA interfaces are most probably very large with the concomitant implications of basic, hydrophobic, and aromatic residues engaged, respectively, in ionic, hydrophobic, and intercalating interactions [34, 35, 36]. The interactions between NC and RT are poorly understood, but they appear to necessitate the RNA template as the scaffolding agent [37, 38]. In that respect the RTp66 subunit with its active site appears to be extremely flexible with notably a large template-binding pocket. These observations favor the notion that the viral proteins NC and RT and the template RNA making up the replication machine exhibit a flexible nature in an active nucleoprotein complex in agreement with the proposal of Uversky [29]. These in vitro and ex vivo studies on retroviral Gag polyproteins and NC proteins have essentially been carried out using HIV-1 (Table 1); additional experiments performed with AlpharetrovirusRSV NCp12 with two zinc fingers flanked by basic residues; NCp10 of the gammaretrovirus MuLV, with a unique zinc finger flanked by basic residues; and of the yeast retrotransposon Ty3 NCp9, with a unique zinc finger and basic residues, gave very similar results with respect to RNA binding, chaperoning, and ribonucleoprotein complex formation in vitro (Table 1).


5. The core protein of HBV and its roles in virus assembly and viral DNA synthesis

HBV is an enveloped virus with a 3.2 kb partially double-stranded DNA genome referred to as rcDNA [7] that is synthesized by reverse transcription of the pgRNA [39]. The core protein contains 183–185 residues corresponding to two domains (Figure 4): the N-terminus (NTD) (residues 1–140) that oligomerizes in a capsid structure linked by a flexible sequence to the basic C-terminal domain (CTD) (residues 150–183) [40, 42, 43]. The core CTD interacts with nucleic acids and is endowed with nucleic acids annealing, matchmaker, and aggregating activities [8, 44].

Figure 4.

HBV core primary sequence. The core protein is divided into two parts: the N-terminus (1–140) and the C-terminus (150–183). The N-terminus is sufficient in vitro for the process of self-assembly [8]. NTD monomer contains a series of five α helices, the third and the fourth helices associate in a four-helix bundle giving the characteristic spikes at the surface of assembled capsids [40]. The C-terminus contains arginine residues essential for the interaction of core with NA an activity that is regulated by the phosphorylation of the seven serine residues [41]. The effect of mutations in the flexible linker between NTD and CTD (141–149) suggests that the orientation of NTD respective to CTD is essential in the multistage process of HBV replication [42].

The HBV core protein orchestrates virus assembly to form an icosahedral capsid [54] (Figure 5). During assembly, HBc specifically recognizes the Pol-pgRNA complex [55], promotes its packaging into nascent particles, and assists rcDNA synthesis by the viral RT and cccDNA maintenance [56, 57, 58] (for review see Seeger and Mason [59]). The processes of RTion and capsid maturation are regulated by CTD phosphorylation/dephosphorylation [41, 60, 61, 62] together with structural rearrangements of the capsid structure [63, 64, 65]; this influences capsid trafficking in virus-producing cells and is driven by an unknown mechanism the viral ribonucleoprotein (vRNP) complex to the nucleus and thus the formation of cccDNA. Else the vRNP is targeted to cellular compartments where they interact with the envelope proteins promoting virus egress [43, 66, 67] (for review see Blondot et al. [68]). HBV secretion remains a challenging issue since different types of viral particles are found in the circulating blood of patients. Despite a heterogeneous distribution from patients to patients, it is estimated that most of the particles are consisting of the sole envelope proteins (HBsAg) as sphere and filaments also referred to as Australian antigen (1014/ml), empty particles (without genome, 1011/ml), RNA-containing virions (106/ml), and complete infectious particles (Dane particles, 109/ml) [49]. The low amount Dane particles remain unclear, and it has been proposed that reverse transcription of the pgRNA triggers a structural change of the capsid (maturation signal), which in turn causes the envelopment and secretion of complete infectious virions [65, 69]. More recently the group of Hu et al. proposed a two-signal model, the first one exposed in the empty particles at the level of the NTD-CTD linker resulting in an interaction with the S protein and the second one exposed in maturate particles at the level of the MBD (matrix-binding domain) to cause an interaction with the L envelope [70, 71] (for review see Liu and Hu [72]). Even though the molecular bases of these two domains remain to be clarified, they both lie on the capsid structure in agreement with the large effect of capsid envelopment by single-point mutations around the hydrophobic pocket in the center of the spikes [73, 74, 75, 76]. Thus the envelopment of the vRNP is closely linked to the HBc protein that represents a critical factor in virus replication and as a matter of fact, a target in the search for antiviral molecules [77, 78].

Figure 5.

HBV replication cycle. (1) Virus attachment to the sodium-taurocholate cotransporting polypeptide (NTCP) and entry [45]. (2) Nucleocapsid release in the cytoplasm upon fusion of the cellular and viral membranes and trafficking to the nucleus [43]. This traffic is probably mediated by the CTD containing NLSs [46]. (3) Nuclear pore attachment of the nucleocapsid and release of the rcDNA (relaxed circular) into the nucleus with reorganization of the capsid [47]. (4) Conversion of the rcDNA into cccDNA (covalently closed circular DNA) and formation of a nucleosome-bound minichromosome, possibly associated with HBx, core protein, histone, and nonhistone cellular proteins [7]. (5) Transcription generating the pre-genomic RNA, precore RNA, preS1/preS2/S mRNAs, and HBx mRNA [48]. (6) Synthesis of the viral proteins by the cell machinery. (7) Production of HBeAg and assembly of S alone with some L protein giving rise to subviral particles. (8) Formation of empty capsids or pgRNA-Pol containing capsids with immature nucleocapsids. Reverse transcription of pgRNA to generate rcDNA is concomitant with the maturation of the nucleocapsid. (9) Both empty and mature particles are embedded by L and S proteins and produced in the supernatant [49]. The egress of particles necessitates the endosomal sorting complexes required for transport (ESCRT) [50] even though naked capsids were shown to be released through the ALIX pathway [51]. (10) Alternatively, the rcDNA-containing particles recycle to the nucleus, amplifying the cccDNA copy numbers [52]. Adapted from Revill et al. [53].


6. The CTD of HBV core protein has nucleic acid chaperone activity

The nucleic acid chaperone activity of the CTD was first suggested by the group of Loeb [66] and of Zlotnick [79]. In the first case, they followed the strand transfer of the initial (−) DNA from the 5′ ε bulge to the 3′ DR1 sequence and (−) DNA elongation. This suggests that the core protein has a nucleic chaperone activity similar to retroviral NC [30, 32, 34, 80, 81]. In the second case, using core constructs mimicking the unphosphorylated or phosphorylated core, they found a correlation between the number of positive charge in the core protein and the RNA density suggesting that the core protein induced RNA structural modification.

The RNA/DNA chaperoning activity of HBc was confirmed using DNA-DNA hybridization and hammerhead ribozyme cleavage in vitro [56]. In the first assay, authors followed the annealing of the DNA version of HIV TAR. This sequence is located in the 5′ end of HIV genome. In addition to its role in the RNA transcription with TAT protein [82, 83], this sequence is essential for the (−) single-stranded transfer along the RT-dependent synthesis of HIV DNA [30, 32, 34, 81]. Interestingly they compared assembled and disassembled HBc particles and found that dissembled HBc was more efficient in DNA duplex formation. Using a series of peptides, they found that this chaperoning activity maps at the CTD and required the four stretches of basic residues (Table 1). When a peptide is containing phosphorylated serine residues at the positions 155, 162, and 170, considered as the three major serine phosphorylation sites, the DNA annealing activity was progressively reduced as a function of the number of phosphorylation sites. Similar results were obtained with the hammerhead ribozyme cleavage assays [27] (Figure 6).

Figure 6.

Annealing activity of HBc and HBc (147–183). (A) TAR(+)/TAR(−) annealing activity of HBc particles (left) and HBc protein (right) as a function of time. TAR(+) was 32P labelled using T4 polynucleotide kinase, purified by PAGE and recovered by ethanol precipitation. TAR(+) and TAR(−) were mixed with HBc in NaCl-containing TRIS buffer. At time points 15 s to 5 min HBc was removed by a proteinase K treatment and reaction stopped by addition of EDTA. TAR DNAs were resolved by 8% PAGE and gels were dried and autoradiographed. (B) TAR(+)/TAR(−) annealing activity of the HBc CTD peptide. This assay was performed as described above at various concentrations for 5 min. Panels A and B were extracted fromFigures 1and3of [56].

The role of HBc nucleic acid annealing and matchmaker activities was assessed using viral particles. Therefore, a plasmid expressing HBV genome with a stop codon in the HBc ORF was cotransfected with a plasmid expressing core in agreement with the fact that HBV competent for the replication can be obtained by trans-complementation assays [84, 85]. Mutations shown to decrease HBc in vitro activity gave rise to an important decrease of HBV DNA synthesis and a loss of viral replication. These results support the notion that HBc has nucleic acid chaperone activity essential for minus-stranded and plus-stranded DNA synthesis along the replication cycle. Nevertheless, the defect observed in viral DNA synthesis could originate from a defect of HBc assembly [86, 87], RNA encapsidation [88, 89], HBc trafficking [46, 68, 90], or HBc maturation/single-stranded blocking model [65, 69, 70, 71] since all these steps require the arginine residues of the C-terminus.


7. Concluding remarks and questions

As for retroviruses that are widespread in living organisms and can rapidly and efficiently circulate and spread in animals, even crossing species barriers, the small basic protein called NC has multiple functions in virus structure, replication, and dissemination. Indeed, NC protein is a helper factor for the RT enzyme and its associated RNAse H activity and also for the integrase enzyme. NC is indeed a chaperoning factor required from the start to the end of viral DNA synthesis as well as for the recruitment of cofactors required for transport (Figure 7). Also they are considered as membrane-less organelles that play key roles in cells such as fine tuning of gene expression, translation, and immune controls via noncoding RNAs. Furthermore, NC is a key factor for driving the recombination reactions fuelling the genetic diversity of the newly made viral particles.

Figure 7.

Formation of nucleoprotein complexes and functions according to the degree of RNA occupancy. With the increasing level of RNA occupancy by the chaperone protein, functions go from selection of the genomic RNA (I), its dimerization (II), to the complete process of reverse transcription (III) or else are targeted to RNP granules (IV).

The HBV C-terminal domain (C-ter) appears to play multiple roles in virus replication in a manner similar to the retroviral NC protein, by chaperoning genome replication ensuring the fidelity of the viral DNA synthesis and its stability once it is complete.

There are many questions on how do such viral nucleoprotein complexes function.

One concerns the process of reverse transcription, i.e., how does the RT enzyme copy the RNA molecule coated by hundreds of such highly basic protein molecules? Another one deals with the permeability of these viral nucleoprotein ensembles [91], i.e., the accessibility of cofactors that can be helper or restriction factors such as cytidine and adenosine deaminases, apolipoprotein B-editing catalytic subunit (APOBEC) [92], or adenosine deaminase acting on RNA-1 (ADAR1) that was recently shown to inhibit HBV replication by enhancing microRNA-122 processing [93]. Furthermore, the recruitment of restriction factors is not an on-off process since a limited accessibility appears to take place for both HIV and HBV, impacting on the genetic diversity of the virus that is a major issue in antiviral treatments [94, 95].

On a more general basis, vRBP’s with chaperoning activities are widespread in the virus world, since they are, for example, encoded for by other virus families such as flaviviruses, notably the core proteins of HCV and dengue viruses, the N protein of coronaviruses and hantaviruses, and the delta antigen of the HDV viroid [96, 97, 98, 99, 100, 101, 102, 103]. In addition, unpublished data show that the N protein of influenza virus has also chaperone activity.

Similar RNA chaperone proteins are found in bacteriophages of the Leviviridaefamily where they regulate vRNA translation and assembly [104]. Also a closer look at the replication of the Q-beta genomic RNA by the viral replicase reveals the chaperoning contribution of the host factors EF-Tu and Ts. These data favor the notion that RNA chaperones may also influence protein conformation and enzymatic activity, raising the possibility that such proteins are Janus chaperones [28, 105, 106].



Personal (JLD) thanks are due to my spouse Anne Napoly and to Yves Mély (Faculty of Pharmacy, Strasbourg) for their continuous support during the past 12 months and to Lada Bozic for her kind understanding. Supports from INSERM, ANRS, and Philippe Roingeard (Faculty of Medicine, Tours) are acknowledged (HdR).


  1. 1. Hayward A, Cornwallis CK, Jern P. Pan-vertebrate comparative genomics unmasks retrovirus macroevolution. Proceedings of the National Academy of Sciences of the United States of America. 2015;112:464-469. DOI: 10.1073/pnas.1414980112
  2. 2. Krupovic M, Blomberg J, Coffin JM, Dasgupta I, Hung F, Geering AD, et al. Ortervirales: New virus order unifying five families of reverse-transcribing viruses. Journal of Virology. 2018;92:1-5. DOI: 10.1128/JVI.00515-18
  3. 3. Budzinska MA, Shackel NA, Urban S, Tu T. Cellular genomic sites of hepatitis B virus DNA integration. Genes. 2018;9:365-383. DOI: 10.3390/genes9070365
  4. 4. Poeschla E. The importance of becoming double-stranded: Innate immunity and the kinetic model of HIV-1 central plus strand synthesis. Virology. 2013;441:1-11. DOI: 10.1016/j.virol.2013.03.010
  5. 5. Lesbats P, Engelman AN, Cherepanov P. Retroviral DNA integration. Chemical Reviews. 2016;116:12730-12757. DOI: 10.1021/acs.chemrev.6b00125
  6. 6. Ferrer M, Henriet S, Chamontin C, Laine S, Mougel M. From cells to virus particles: Quantitative methods to monitor RNA packaging. Viruses. 2016;8:239-255. DOI: 10.3390/v8080239
  7. 7. Nassal M. HBV cccDNA: Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut. 2015;64:1972-1984. DOI: 10.1136/gutjnl-2015-309809
  8. 8. Venkatakrishnan B, Zlotnick A. The structural biology of hepatitis B virus: Form and function. Annual Review of Virology. 2016;3:429-451. DOI: 10.1146/annurev-virology-110615-042238
  9. 9. Faust TB, Binning JM, Gross JD, Frankel AD. Making sense of multifunctional proteins: Human immunodeficiency virus type 1 accessory and regulatory proteins and connections to transcription. Annual Review of Virology. 2017;4:241-260. DOI: 10.1146/annurev-virology-101416-041654
  10. 10. McNaughton AL, D’Arienzo V, Ansari MA, Lumley SF, Littlejohn M, Revill P, et al. Insights from deep sequencing of the HBV genome-unique, tiny, and misunderstood. Gastroenterology. 2019;156:384-399. DOI: 10.1053/j.gastro.2018.07.058
  11. 11. Han GZ, Worobey M. An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathogens. 2012;8:e1002790. DOI: 10.1371/journal.ppat.1002790
  12. 12. Lauber C, Seitz S, Mattei S, Suh A, Beck J, Herstein J, et al. Deciphering the origin and evolution of hepatitis B viruses by means of a family of non-enveloped fish viruses. Cell Host & Microbe. 2017;22:387-399.e386. DOI: 10.1016/j.chom.2017.07.019
  13. 13. Semrad K, Green R, Schroeder R. RNA chaperone activity of large ribosomal subunit proteins fromEscherichia coli. RNA. 2004;10:1855-1860. DOI: 10.1261/rna.7121704
  14. 14. Rajkowitsch L, Chen D, Stampfl S, Semrad K, Waldsich C, Mayer O, et al. RNA chaperones, RNA annealers and RNA helicases. RNA Biology. 2007;4:118-130. DOI: 10.4161/rna.4.3.5445
  15. 15. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, Roques BP. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. Journal of Molecular Biology. 1995;254:523-537
  16. 16. Sundquist WI, Krausslich HG. HIV-1 assembly, budding, and maturation. Cold Spring Harbor Perspectives in Medicine. 2012;2:a006924. DOI: 10.1101/cshperspect.a006924
  17. 17. Kerviel A, Thomas A, Chaloin L, Favard C, Muriaux D. Virus assembly and plasma membrane domains: Which came first? Virus Research. 2013;171:332-340. DOI: 10.1016/j.virusres.2012.08.014
  18. 18. Scarlata S, Carter C. Role of HIV-1 Gag domains in viral assembly. Biochimica et Biophysica Acta (BBA)—Biomembranes. 2003;1614:62-72. DOI: 10.1016/S0005-2736(03)00163-9
  19. 19. Mailler E, Bernacchi S, Marquet R, Paillart JC, Vivet-Boudou V, Smyth RP. The life-cycle of the HIV-1 Gag-RNA complex. Viruses. 2016;8:248-267. DOI: 10.3390/v8090248
  20. 20. Lingappa JR, Reed JC, Tanaka M, Chutiraka K, Robinson BA. How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle. Virus Research. 2014;193:89-107. DOI: 10.1016/j.virusres.2014.07.001
  21. 21. Lee S-K, Potempa M, Swanstrom R. The choreography of HIV-1 proteolytic processing and virion assembly. The Journal of Biological Chemistry. 2012;287:40867-40874. DOI: 10.1074/jbc.R112.399444
  22. 22. Muriaux D, Darlix JL. Properties and functions of the nucleocapsid protein in virus assembly. RNA Biology. 2010;7:744-753. DOI: 10.4161/rna.7.6.14065
  23. 23. Campbell EM, Hope TJ. HIV-1 capsid: The multifaceted key player in HIV-1 infection. Nature Reviews Microbiology. 2015;13:471-483. DOI: 10.1038/nrmicro3503
  24. 24. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. Journal of Virology. 1993;67:2182-2190
  25. 25. Rusert P, Fischer M, Joos B, Leemann C, Kuster H, Flepp M, et al. Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology. 2004;326:113-129. DOI: 10.1016/j.virol.2004.05.022
  26. 26. Klasse PJ. Molecular determinants of the ratio of inert to infectious virus particles. Progress in Molecular Biology and Translational Science. 2015;129:285-326. DOI: 10.1016/bs.pmbts.2014.10.012
  27. 27. Herschlag D. RNA chaperones and the RNA folding problem. The Journal of Biological Chemistry. 1995;270:20871-20874
  28. 28. Kovacs D, Rakacs M, Agoston B, Lenkey K, Semrad K, Schroeder R, et al. Janus chaperones: Assistance of both RNA- and protein-folding by ribosomal proteins. FEBS Letters. 2009;583:88-92. DOI: 10.1016/j.febslet.2008.11.049
  29. 29. Uversky VN. Intrinsic disorder-based protein interactions and their modulators. Current Pharmaceutical Design. 2013;19:4191-4213. DOI: 10.2174/1381612811319230005
  30. 30. Godet J, Mely Y. Biophysical studies of the nucleic acid chaperone properties of the HIV-1 nucleocapsid protein. RNA Biology. 2010;7:687-699. DOI: 10.4161/rna.7.6.13616
  31. 31. Levin JG, Guo J, Rouzina I, Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: Critical role in reverse transcription and molecular mechanism. Progress in Nucleic Acid Research and Molecular Biology. 2005;80:217-286
  32. 32. Rein A. Nucleic acid chaperone activity of retroviral Gag proteins. RNA Biology. 2010;7:700-705
  33. 33. Summers MF, Karn J. Special issue: Structural and molecular biology of HIV. Journal of Molecular Biology. 2011;410:489-490. DOI: 10.1016/j.jmb.2011.05.001
  34. 34. Darlix JL, de Rocquigny H, Mauffret O, Mely Y. Retrospective on the all-in-one retroviral nucleocapsid protein. Virus Research. 2014;193:2-15. DOI: 10.1016/j.virusres.2014.05.011
  35. 35. Hentze MW, Castello A, Schwarzl T, Preiss T. A brave new world of RNA-binding proteins. Nature Reviews Molecular Cell Biology. 2018;19:327-341. DOI: 10.1038/nrm.2017.130
  36. 36. Rene B, Mauffret O, Fosse P. Retroviral nucleocapsid proteins and DNA strand transfers. Biochimie Open. 2018;7:10-25. DOI: 10.1016/j.biopen.2018.07.001
  37. 37. Druillennec S, Caneparo A, de Rocquigny H, Roques BP. Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. The Journal of Biological Chemistry. 1999;274:11283-11288
  38. 38. Lener D, Tanchou V, Roques BP, Le Grice SF, Darlix JL. Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. The Journal of Biological Chemistry. 1998;273:33781-33786
  39. 39. Nassal M. Hepatitis B viruses: Reverse transcription a different way. Virus Research. 2008;134:235-249. DOI: 10.1016/j.virusres.2007.12.024
  40. 40. Wynne SA, Crowther RA, Leslie AG. The crystal structure of the human hepatitis B virus capsid. Molecular Cell. 1999;3:771-780
  41. 41. Heger-Stevic J, Zimmermann P, Lecoq L, Bottcher B, Nassal M. Hepatitis B virus core protein phosphorylation: Identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure. PLoS Pathogens. 2018;14:e1007488. DOI: 10.1371/journal.ppat.1007488
  42. 42. Liu K, Luckenbaugh L, Ning X, Xi J, Hu J. Multiple roles of core protein linker in hepatitis B virus replication. PLoS Pathogens. 2018;14:e1007085. DOI: 10.1371/journal.ppat.1007085
  43. 43. Gallucci L, Kann M. Nuclear import of hepatitis B virus capsids and genome. Viruses. 2017;9:21-40. DOI: 10.3390/v9010021
  44. 44. Diab A, Foca A, Zoulim F, Durantel D, Andrisani O. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals. Antiviral Research. 2018;149:211-220. DOI: 10.1016/j.antiviral.2017.11.015
  45. 45. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012;1:e00049. DOI: 10.7554/eLife.00049
  46. 46. Li HC, Huang EY, Su PY, Wu SY, Yang CC, Lin YS, et al. Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathogens. 2010;6:e1001162. DOI: 10.1371/journal.ppat.1001162
  47. 47. Rabe B, Delaleau M, Bischof A, Foss M, Sominskaya I, Pumpens P, et al. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathogens. 2009;5:e1000563. DOI: 10.1371/journal.ppat.1000563
  48. 48. Block TM, Guo H, Guo J-T. Molecular virology of hepatitis B virus for clinicians. Clinics in Liver Disease. 2007;11:685-706. DOI: 10.1016/j.cld.2007.08.002
  49. 49. Hu J, Liu K. Complete and incomplete hepatitis B virus particles: Formation, function, and application. Viruses. 2017;9:56-73. DOI: 10.3390/v9030056
  50. 50. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S, Ahlquist P. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:10205-10210. DOI: 10.1073/pnas.0704000104
  51. 51. Bardens A, Doring T, Stieler J, Prange R. Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner. Cellular Microbiology. 2011;13:602-619. DOI: 10.1111/j.1462-5822.2010.01557.x
  52. 52. Prange R. Host factors involved in hepatitis B virus maturation, assembly, and egress. Medical Microbiology and Immunology. 2012;201:449-461. DOI: 10.1007/s00430-012-0267-9
  53. 53. Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, et al. A global scientific strategy to cure hepatitis B. The Lancet Gastroenterology and Hepatology. 2019;4:545-558. DOI: 10.1016/s2468-1253(19)30119-0
  54. 54. Zlotnick A, Venkatakrishnan B, Tan Z, Lewellyn E, Turner W, Francis S. Core protein: A pleiotropic keystone in the HBV lifecycle. Antiviral Research. 2015;121:82-93. DOI: 10.1016/j.antiviral.2015.06.020
  55. 55. Lott L, Beames B, Notvall L, Lanford RE. Interaction between hepatitis B virus core protein and reverse transcriptase. Journal of Virology. 2000;74:11479-11489
  56. 56. Chu TH, Liou AT, Su PY, Wu HN, Shih C. Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein. Journal of Virology. 2014;88:2530-2543. DOI: 10.1128/JVI.03235-13
  57. 57. Hirsch RC, Lavine JE, Chang LJ, Varmus HE, Ganem D. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature. 1990;344:552-555. DOI: 10.1038/344552a0
  58. 58. Nassal M, Junker-Niepmann M, Schaller H. Translational inactivation of RNA function: Discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell. 1990;63:1357-1363
  59. 59. Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479-480:672-686. DOI: 10.1016/j.virol.2015.02.031
  60. 60. Liao W, Ou JH. Phosphorylation and nuclear localization of the hepatitis B virus core protein: Significance of serine in the three repeated SPRRR motifs. Journal of Virology. 1995;69:1025-1029
  61. 61. Ning X, Basagoudanavar SH, Liu K, Luckenbaugh L, Wei D, Wang C, et al. Capsid phosphorylation state and hepadnavirus virion secretion. Journal of Virology. 2017;91:1-16. DOI: 10.1128/jvi.00092-17
  62. 62. Zhao Q , Hu Z, Cheng J, Wu S, Luo Y, Chang J, et al. Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation. Journal of Virology. 2018;92:1-18. DOI: 10.1128/jvi.02139-17
  63. 63. Bottcher B, Vogel M, Ploss M, Nassal M. High plasticity of the hepatitis B virus capsid revealed by conformational stress. Journal of Molecular Biology. 2006;356:812-822. DOI: 10.1016/j.jmb.2005.11.053
  64. 64. Meng D, Hjelm RP, Hu J, Wu J. A theoretical model for the dynamic structure of hepatitis B nucleocapsid. Biophysical Journal. 2011;101:2476-2484. DOI: 10.1016/j.bpj.2011.10.002
  65. 65. Roseman AM, Berriman JA, Wynne SA, Butler PJ, Crowther RA. A structural model for maturation of the hepatitis B virus core. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:15821-15826. DOI: 10.1073/pnas.0504874102
  66. 66. Lewellyn EB, Loeb DD. The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. Journal of Virology. 2011;85:1298-1309. DOI: 10.1128/JVI.01957-10
  67. 67. Schmitz A, Schwarz A, Foss M, Zhou L, Rabe B, Hoellenriegel J, et al. Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket. PLoS Pathogens. 2010;6:e1000741. DOI: 10.1371/journal.ppat.1000741
  68. 68. Blondot ML, Bruss V, Kann M. Intracellular transport and egress of hepatitis B virus. Journal of Hepatology. 2016;64:S49-S59. DOI: 10.1016/j.jhep.2016.02.008
  69. 69. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 1982;29:403-415. DOI: 10.1016/0092-8674(82)90157-x
  70. 70. Ning X, Luckenbaugh L, Liu K, Bruss V, Sureau C, Hu J. Common and distinct capsid and surface protein requirements for secretion of complete and genome-free hepatitis B virions. Journal of Virology. 2018;92:1-18. DOI: 10.1128/jvi.00272-18
  71. 71. Ning X, Nguyen D, Mentzer L, Adams C, Lee H, Ashley R, et al. Secretion of genome-free hepatitis B virus—Single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathogens. 2011;7:e1002255. DOI: 10.1371/journal.ppat.1002255
  72. 72. Liu K, Hu J. Secretion of empty or complete hepatitis B virions: Envelopment of empty capsids versus mature nucleocapsids. Future Virology. 2019;14:95-105. DOI: 10.2217/fvl-2018-0128
  73. 73. Bottcher B, Nassal M. Structure of mutant hepatitis B core protein capsids with premature secretion phenotype. Journal of Molecular Biology. 2018;430:4941-4954. DOI: 10.1016/j.jmb.2018.10.018
  74. 74. Pastor F, Herrscher C, Patient R, Moreau A, Burlaud-Gaillard J, Seigneuret F, et al. Direct interaction between hepatitis B virus core and envelope proteins analyzed in a cellular context. Scientific Reports. 7 November 2019;9(1):16178-16190. DOI: 10.1038/s41598-019-52824-z
  75. 75. Ponsel D, Bruss V. Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. Journal of Virology. 2003;77:416-422
  76. 76. Yuan TT, Sahu GK, Whitehead WE, Greenberg R, Shih C. The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. Journal of Virology. 1999;73:5731-5740
  77. 77. Martinez MG, Testoni B, Zoulim F. Biological basis for functional cure of chronic hepatitis B. Journal of Viral Hepatitis. 2019;26:786-794. DOI: 10.1111/jvh.13090
  78. 78. Testoni B, Durantel D, Zoulim F. Novel targets for hepatitis B virus therapy. Liver International: Official Journal of the International Association for the Study of the Liver. 2017;37(Suppl 1):33-39. DOI: 10.1111/liv.13307
  79. 79. Wang JC, Dhason MS, Zlotnick A. Structural organization of pregenomic RNA and the carboxy-terminal domain of the capsid protein of hepatitis B virus. PLoS Pathogens. 2012;8:e1002919. DOI: 10.1371/journal.ppat.1002919
  80. 80. Olson ED, Musier-Forsyth K. Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly. Seminars in Cell and Developmental Biology. 2019;86:129-139. DOI: 10.1016/j.semcdb.2018.03.015
  81. 81. Rein A, Datta SA, Jones CP, Musier-Forsyth K. Diverse interactions of retroviral Gag proteins with RNAs. Trends in Biochemical Sciences. 2011;36:373-380. DOI: 10.1016/j.tibs.2011.04.001
  82. 82. Gatignol A. Transcription of HIV: Tat and cellular chromatin. Advances in Pharmacology (San Diego, Calif.). 2007;55:137-159. DOI: 10.1016/s1054-3589(07)55004-0
  83. 83. Karn J. The molecular biology of HIV latency: Breaking and restoring the Tat-dependent transcriptional circuit. Current Opinion in HIV and AIDS. 2011;6:4-11. DOI: 10.1097/COH.0b013e328340ffbb
  84. 84. Lott L, Notvall L, Lanford RE. Transcomplementation of core and polymerase functions of the woolly monkey and human hepatitis B viruses. Virology. 2003;308:330-339. DOI: 10.1016/s0042-6822(03)00003-5
  85. 85. Protzer U, Nassal M, Chiang P-W, Kirschfink M, Schaller H. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proceedings of the National Academy of Sciences. 1999;96:10818. DOI: 10.1073/pnas.96.19.10818
  86. 86. Ludgate L, Liu K, Luckenbaugh L, Streck N, Eng S, Voitenleitner C, et al. Cell-free hepatitis B virus capsid assembly dependent on the core protein C-terminal domain and regulated by phosphorylation. Journal of Virology. 2016;90:5830-5844. DOI: 10.1128/JVI.00394-16
  87. 87. Newman M, Chua PK, Tang FM, Su PY, Shih C. Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system. Journal of Virology. 2009;83:10616-10626. DOI: 10.1128/jvi.00749-09
  88. 88. Gallina A, Bonelli F, Zentilin L, Rindi G, Muttini M, Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. Journal of Virology. 1989;63:4645-4652
  89. 89. Gazina EV, Fielding JE, Lin B, Anderson DA. Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. Journal of Virology. 2000;74:4721-4728
  90. 90. Kann M, Sodeik B, Vlachou A, Gerlich WH, Helenius A. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. The Journal of Cell Biology. 1999;145:45-55
  91. 91. Yu X, Jin L, Jih J, Shih C, Zhou ZH. 3.5A cryoEM structure of hepatitis B virus core assembled from full-length core protein. PLoS ONE. 2013;8:e69729. DOI: 10.1371/journal.pone.0069729
  92. 92. Nair S, Zlotnick A. Asymmetric modification of hepatitis B virus (HBV) genomes by an endogenous cytidine deaminase inside HBV cores informs a model of reverse transcription. Journal of Virology. 2018;92:15261-15269. DOI: 10.1128/jvi.02190-17
  93. 93. Liu G, Ma X, Wang Z, Wakae K, Yuan Y, He Z, et al. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing. The Journal of Biological Chemistry. 2019;294:14043-14054. DOI: 10.1074/jbc.RA119.007970
  94. 94. Chen Y, Hu J, Cai X, Huang Y, Zhou X, Tu Z, et al. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antiviral Research. 2018;149:16-25. DOI: 10.1016/j.antiviral.2017.11.006
  95. 95. Cuevas JM, Geller R, Garijo R, Lopez-Aldeguer J, Sanjuan R. Extremely high mutation rate of HIV-1 in vivo. PLoS Biology. 2015;13:e1002251. DOI: 10.1371/journal.pbio.1002251
  96. 96. Huang ZS, Su WH, Wang JL, Wu HN. Selective strand annealing and selective strand exchange promoted by the N-terminal domain of hepatitis delta antigen. The Journal of Biological Chemistry. 2003;278:5685-5693. DOI: 10.1074/jbc.M207938200
  97. 97. Huang ZS, Wu HN. Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides. The Journal of Biological Chemistry. 1998;273:26455-26461. DOI: 10.1074/jbc.273.41.26455
  98. 98. Ivanyi-Nagy R, Kanevsky I, Gabus C, Lavergne JP, Ficheux D, Penin F, et al. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions. Nucleic Acids Research. 2006;34:2618-2633
  99. 99. Mir MA, Panganiban AT. Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein. Journal of Virology. 2006;80:6276-6285. DOI: 10.1128/jvi.00147-06
  100. 100. Pong WL, Huang ZS, Teoh PG, Wang CC, Wu HN. RNA binding property and RNA chaperone activity of dengue virus core protein and other viral RNA-interacting proteins. FEBS Letters. 2011;585:2575-2581. DOI: 10.1016/j.febslet.2011.06.038
  101. 101. Wang SH, Syu WJ, Huang KJ, Lei HY, Yao CW, King CC, et al. Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. The Journal of General Virology. 2002;83:3093-3102. DOI: 10.1099/0022-1317-83-12-3093
  102. 102. Xu X, Severson W, Villegas N, Schmaljohn CS, Jonsson CB. The RNA binding domain of the hantaan virus N protein maps to a central, conserved region. Journal of Virology. 2002;76:3301-3308. DOI: 10.1128/jvi.76.7.3301-3308.2002
  103. 103. Zuniga S, Sola I, Moreno JL, Sabella P, Plana-Duran J, Enjuanes L. Coronavirus nucleocapsid protein is an RNA chaperone. Virology. 2007;357:215-227. DOI: 10.1016/j.virol.2006.07.046
  104. 104. Rumnieks J, Tars K. Protein-RNA interactions in the single-stranded RNA bacteriophages. Sub-Cellular Biochemistry. 2018;88:281-303. DOI: 10.1007/978-981-10-8456-0_13
  105. 105. Kulkarni P, Uversky VN. Intrinsically disordered proteins and the Janus challenge. Biomolecules. 2018;8. DOI: 10.3390/biom8040179
  106. 106. Takeshita D, Tomita K. Assembly of Q[beta] viral RNA polymerase with host translational elongation factors EF-Tu and -Ts. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:15733-15738. DOI: 10.1073/pnas.1006559107

Written By

Jean Luc Darlix and Hugues de Rocquigny

Submitted: May 27th, 2019 Reviewed: December 2nd, 2019 Published: June 17th, 2020